Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCharacterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Journal of Pharmacology and Experimental Therapeutics, 08/27/09
Gavalda A et al. – These results indicate that aclidinium is a potent muscarinic antagonist with a fast onset of action, a long duration of effect and a favorable cardiovascular safety profile.
Related Articles
Beta-2 agonists in sport. Are the Anti-Doping rules meeting the needs of asthmatic athletes?
British Journal of Sports Medicine, 12/15/09
Relevance Score: 80%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor